← Back to Clinical Trials
Recruiting NCT05977218

DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Type 2 Diabetes
Sponsor Linkoeping University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 900
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2025-08-25
Completion 2026-12-31
Interventions
FoodSwitch

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.

Eligibility Criteria

Inclusion criteria: * Age between 18 and 75 years * Self-reported type 2 diabetes with a duration of ≥2 years * Regularly grocery shopping Exclusion criteria: * No access to BankID (a digital identification system commonly used in Sweden) * Failure to complete eligibility screening and run-in periods

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE TYPE 2 DIABETES TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}